To protect against the risk of importation and transmission of yellow fever in Singapore, all travellers, including Singapore residents, with travel history to countries with risk of yellow fever transmission [i.e. wholly or partly endemic for yellow fever] in the six days prior to arrival in Singapore are required to have a valid yellow fever vaccination certificate and present it to the ICA officer at the immigration counter upon arriving in Singapore.
Travellers without a valid yellow fever vaccination certificate [including those who are ineligible to receive the vaccination e.g. children aged 1 year old and below and individuals with contraindications], are liable to be quarantined under Section 31 of the Infectious Disease Act, for up to six days upon arrival in Singapore. Non-residents who refuse quarantine will be turned away and returned to his/her place of origin or last port of embarkation.
This approach is consistent with the World Health Organization's recommendations in the International Health Regulations [IHR 2005].
The International Certificate of Vaccination for yellow fever is only considered valid 10 days after vaccination and the validity lasts for the life of the person vaccinated.
Please ask your doctor to review your suitability for the yellow fever vaccine.
Please refer to MOH website [//www.moh.gov.sg/diseases-updates/yellow-fever] for more information on yellow fever.
Countries with risk of yellow fever transmission in whole or in part, correct as of 7 February 2022
Africa
Angola | Equatorial Guinea | Mauritania |
Benin | Ethiopia | Niger |
Burkina Faso | Gabon | Nigeria |
Burundi | Gambia | Senegal |
Cameroon | Ghana | Sierra Leone |
Central African Republic | Guinea | South Sudan |
Chad | Guinea-Bissau | Sudan |
Congo | Kenya | Togo |
Cote d’lvoire | Liberia | Uganda |
Democratic Republic of the Congo | Mali |
Latin America
Argentina | French Guiana | Peru |
Bolivia | Guyana | Suriname |
Brazil | Panama | Trinidad and Tobago |
Colombia | Paraguay | Venezuela |
Ecuador |
- Global
-
Regions
WHO Regional websites
- Home
- Health Topics
- All topics »
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
-
Resources »
- Fact sheets
- Facts in pictures
- Multimedia
- Publications
- Questions & answers
- Tools and toolkits
- Popular »
- Air pollution
- Coronavirus disease [COVID-19]
- Hepatitis
- Monkeypox
- Countries
- All countries »
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- R
- S
- T
- U
- V
- W
- X
- Y
- Z
- Regions »
- Africa
- Americas
- South-East Asia
- Europe
- Eastern Mediterranean
- Western Pacific
- WHO in countries »
- Statistics
- Cooperation strategies
- Ukraine emergency
- Newsroom
-
All news »
- News releases
- Statements
- Campaigns
- Commentaries
- Events
- Feature stories
- Speeches
- Spotlights
- Newsletters
- Photo library
- Media distribution list
- Headlines »
- Emergencies
- Focus on »
- Afghanistan crisis
- COVID-19 pandemic
- Northern Ethiopia crisis
- Syria crisis
- Ukraine emergency
- Monkeypox outbreak
- Greater Horn of Africa crisis
- Latest »
- Disease Outbreak News
- Travel advice
- Situation reports
- Weekly Epidemiological Record
- WHO in emergencies »
- Surveillance
- Research
- Funding
- Partners
- Operations
- Independent Oversight and Advisory Committee
- Data
- Data at WHO »
- Global Health Estimates
- Health SDGs
- Mortality Database
- Data collections
- Dashboards »
- COVID-19 Dashboard
- Triple Billion Dashboard
- Health Inequality Monitor
- Highlights »
- Global Health Observatory
- SCORE
- Insights and visualizations
- Data collection tools
-
Reports »
- World Health Statistics 2022
- COVID excess deaths
- DDI IN FOCUS: 2022
- About WHO
- About WHO »
- People
- Teams
- Structure
- Partnerships and collaboration
- Collaborating centres
- Networks, committees and advisory groups
- Transformation
- Our Work »
- General Programme of Work
- WHO Academy
- Activities
- Initiatives
- Funding »
- Investment case
- WHO Foundation
- Accountability »
- Audit
- Budget
- Financial statements
- Programme Budget Portal
- Results Report
-
Governance »
- World Health Assembly
- Executive Board
- Election of Director-General
- Governing Bodies website
- Home/
- Publications/
- m/
- item/
- Lifetime validity of one dose of Yellow fever vaccine
Amendment to Annex 7 of IHR [2005] 24 May 2014 | Publication
WHO Team
Emergency Preparedness ADGO